Enteropathy-associated T-cell lymphoma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Nima Nasiri (talk | contribs) Created page with "===Secondary Prevention=== There are no established measures for the secondary prevention of enteropathy-associated T cell lymphoma." |
Nima Nasiri (talk | contribs) |
||
| Line 1: | Line 1: | ||
===Secondary Prevention=== | ===Secondary Prevention=== | ||
There are no established measures for the secondary prevention of enteropathy-associated T cell lymphoma. | There are no established measures for the secondary prevention of enteropathy-associated T cell lymphoma. | ||
==References== | |||
{{reflist|2}} | |||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] | |||
[[Category:Gastroenterology]] | |||
Revision as of 19:42, 9 January 2019
Secondary Prevention
There are no established measures for the secondary prevention of enteropathy-associated T cell lymphoma.